Chugai
Recruiting Site

INFORMATION

  • 25.07.07

    Summer event and Applications for Doctoral Graduate Recruitment are now closed. Thank you for the many applications received.

  • 25.04.01

    Click here for FY2027 New Graduate My Page.CHUGAI Recruit HP for the further information.

COMPANY

We share the organizational characteristics of Chugai Pharmaceutical that successively creates innovations here.

Chugai Life Science Park Yokohama

Introduce the Green Innovation Village

PEOPLE

We introduce a wide variety of employees with diverse characteristics
who are actively working while making use of
Chugai Pharmaceutical's innovative technologies here.

VIEW ALL

Yuma Wakamiya

Research Div.,
Discovery Chemistry Dept.
Since 2020

Miki Kamioka

Research Div.
Protein Science Dept.
Since 2017

Takashi Suzuki

Research Div.
Discovery Biologics Dept.
Since 2016

Kazuki Yamaguchi

Research Div.
Discovery Pharmacology Dept.
Since 2014

Junko Taketo

Research Div.
Safety Assessment Dept.
Since 2006

Yuichiro Shimizu

Chugai Pharmabody
Research Pte. Ltd.
Since 2010

Reiji Teramoto

Research Div.
Discovery Technology Dept.
Since 2010

Wataru Tanaka

Pharmaceutical Technology Div.
API Process Development Dept.
Since 2019

Misato Takagi

Pharmaceutical Technology Div.
Analytical Development Dept.
Since 2017

Azusa Toya

Pharmaceutical Technology Div.
API Process Development Dept.
Since 2013

Yuuki Kojima

Pharmaceutical Technology Div.
Production Engineering Dept.
Since 2006

Kotaro Iwasaki

Pharmaceutical Technology Div.
API Process Development Dept.
Since 2017

Naoko Suzuki

Pharmaceutical Technology Div.
CMC Development Dept.
Since 2016

Mayu Tomita

Medical Affairs Div.
Product Research Dept.
Since 2020

Atsuko Murai

Translational Research Div.
Non-clinical
Safety Assessment Dept.
Since 2018

Hitomi Keo

Project & Lifecycle
Management Unit
Regulatory Affairs Dept.
Since 2019

Masataka Hirota

Project & Lifecycle
Management Unit
Regulatory Affairs Dept.
Since 2007

Shuhei Tokiwa

Quality & Regulatory
Compliance Unit
Quality Initiative Dept.
Since 2019

Maiko Takada

Quality & Regulatory
Compliance Unit
Quality Assurance Dept.
Since 2002

Kiriko Kato

Quality & Regulatory
Compliance Unit
Quality Assurance Dept.
Since 2017

Yuya Ueda

Drug Safety Div.
Safety Science Dept.
Since 2017

Ryunosuke Tanabe

Drug Safety Div.
Risk Communication Dept.
Since 2018

Kumiko Maie

Drug Safety Div.
Pharmacovigilance Dept.
Since 2006

Shinichi Matsuda

Drug Safety Div.
Drug Safety
Data Management Dept.
Since 2007

Chunan Chen

Translational Research Div.
Early Clinical Development Dept.
Since 2018

Ryoto Ozaki

Clinical Development Div.
Biometrics Dept.
Since 2017

Yoshiaki Motomura

Clinical Development Div.
Oncology
Clinical Development Dept.
Since 2019

Yosuke Murakami

Translational Research Div.
Early Clinical Development Dept.
Since 2016

Eisuke Ueda

Clinical Development Div.
Clinical Science & Strategy Dept.
Since 2006

Akari Tanaka

Clinical Development Div.
Clinical Science & Strategy Dept.
Since 2015

Takatsugu Narikiyo

Clinical Development Div.
Clinical Study Management Dept.
Since 2006

Kai Tanaka

Translational Research Div.
Pharmaceutical Science Dept.
Since 2016

Naoki Kotani

Translational Research Div.
Pharmaceutical Science Dept.
Since 2012

Kei Harufuku

Medical Sciences Dept.
Medical Affairs Div.
Since 2018

Shiori Koyama

Marketing & Sales Div.
Kanto-Minami Regional Management Office
Tokyo Branch 2
Since 2015

Satoko Miura

Marketing & Sales Div.
Primary Unit
Osaka-Minami Sales Group
Since 2010

Kohei Abe

Finance & Accounting Dept.
Since 2010

Song Juhee

Partnering Dept.
Since 2015

Masashi Nakatomi

Digital Strategy Dept,
Digital and IT Management Div.
Mid-career recruit in 2018